GEVONasdaqIndustrial Organic ChemicalsFiscal year ends December 31
Gevo, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.13−0.04 (-3.42%)
Close on Oct 19, 2026
- Market cap
- $267.87M
- P/E (TTM)
- –
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
46.9%+217.9 pts over 5 years
Operating margin
-12.6%+474.4 pts over 5 years
Net margin
-21.1%+704.8 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +849.3% | +415.1% | +96.1% | +18.2% | |
| Gross profit | +1433.5% | – | – | – |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | -63.3% | -36.7% | -7.1% | |
| Return on assets | -34.6% | -32.7% | -5.2% | |
| Current ratio | 0.96 | 16.88 | 1.82 | |
| Debt to equity | – | 0.01 | 0.35 | |
| Net debt to EBITDA | – | 3.66× | 16.35× | |
| Interest coverage | -3.1× | -12.9× | -1.2× | |
| Inventory turnover | 10.7× | 5.3× | 7.2× | |
| Capex to revenue | 21.8% | 112.3% | 18.8% | |
| Diluted shares | 0M | 57M | 234M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Gevo generated $217.09M from operations and spent $281.21M on capital expenditure, dividends and share buybacks. 98% of that went back into the business.
Generated
$217.09M
Used
$281.21M
Capital expenditure$276.50M98%Dividends$00%Share buybacks$4.71M2%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin-21.1%
×Asset turnover0.25×
×Equity multiplier1.36×
=Return on equity, FY2025-7.1%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | -21.1% | 0.25× | 1.36× | -7.1% |
| FY2024 | -464.9% | 0.03× | 1.18× | -15.0% |
| FY2023 | -385.0% | 0.03× | 1.16× | -11.4% |
| FY2022 | -8341.0% | 0.00× | 1.17× | -17.0% |
| FY2021 | -11107.5% | 0.00× | 1.15× | -17.1% |
| FY2020 | -725.9% | 0.05× | 1.12× | -36.7% |
| FY2019 | -117.0% | 0.24× | 1.24× | -35.5% |
| FY2018 | -85.1% | 0.34× | 1.29× | -36.7% |
| FY2017 | -89.4% | 0.27× | 1.51× | -37.1% |
| FY2016 | -136.8% | 0.25× | 1.83× | -63.3% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
4of 9 tests passed in fiscal 2025. Scores of 7 to 9 are usually read as strong.
- ProfitableNet income above zero-$33.84M
- Cash generatingOperating cash flow above zero-$13.40M
- Return on assets improvedROA up on the prior year-12.1% → -5.8%
- Earnings backed by cashOperating cash flow above net income-$13.40M vs -$33.84M
- Less leverageLong-term debt to assets fell11.5% → 22.9%
- Better liquidityCurrent ratio rose8.36 → 1.82
- No dilutionShare count did not rise232M → 234M
- Gross margin improvedGross margin up on the prior year29.05% → 46.92%
- More efficientAsset turnover rose0.03 → 0.27